Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Decisions and ethical issues among BRCA carriers and the use of preimplantation genetic diagnosis.

Minerva medica - 1 Oct 2009

Quinn G P, Vadaparampil S T, Bower B, Friedman S, Keefe D L

Abstract excerpt

The lifetime risks for both breast and ovarian cancer for BRCA mutation carriers far exceeds the general population risk of 13% for breast cancer and 1.4% for ovarian cancer. BRCA carriers have unique and medically complicated decisions to make regarding their cancer treatment or risk reduction....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Decision Making
Share to Genes, BRCA1
Share to Genes, BRCA2

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Counseling

Share to Practice Guidelines as Topic

Share to Preimplantation Diagnosis

Share to Prenatal Diagnosis

Share to Reproductive Techniques, Assisted

Source

Identifiers

PMID: 19910890

Genes

PGD

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-19910890-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Decisions and ethical issues among BRCA carriers and the use of preimplantation genetic diagnosis.PMID 19910890Read ↗

Decision-making on preimplantation genetic diagnosis and prenatal diagnosis: a challenge for couples with hereditary breast and ovarian cancer.Semantic proximity Read ↗

BRCA1/2 pathogenetic variant carriers and reproductive decisions: Gender differences and factors associated with the choice of preimplantation genetic diagnosis (PGD) and prenatal diagnosis (PND).Semantic proximity Read ↗

Preimplantation genetic diagnosis for BRCA1/2—a novel clinical experienceSemantic proximity Read ↗

BRCA1/2 testing for genetic susceptibility to cancer after 25 years: A scoping review and a primer on ethical implications.Semantic proximity Read ↗

BRCA carriers' thoughts on risk management in relation to preimplantation genetic diagnosis and childbearing: when too many choices are just as difficult as none.Semantic proximity Read ↗

Cancer risk reduction and reproductive concerns in female BRCA1/2 mutation carriers.Semantic proximity Read ↗

Ethical issues in breast and ovarian cancer genetic counseling.Semantic proximity Read ↗

Genetic testing for breast and ovarian cancer: ethical, legal, and psychosocial considerations.Semantic proximity Read ↗

Views of BRCA gene mutation carriers on preimplantation genetic diagnosis as a reproductive option for hereditary breast and ovarian cancer.Semantic proximity Read ↗

'The BRCA clock is ticking!': negotiating medical concerns and reproductive goals in preimplantation genetic diagnosis.Semantic proximity Read ↗

BRCA1 and BRCA2 gene mutations: decision-making dilemmas concerning testing and management.Semantic proximity Read ↗

Reproductive Decision-Making in Women with BRCA1/2 Mutations.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.